Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Mech Dev ; 154: 203-207, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-30031069

RESUMEN

The transcription factor Hif-1α regulates epithelial to mesenchymal transition and neural crest cell chemotaxis in Xenopus. Hif-1α is only stabilised under low oxygen levels, and the in vivo stabilisation of this factor in neural crest cells is poorly understood. Multiple oxygen-independent Hif-1α regulators have been described in cell cultures and cancer models. Among these, the PDGF pathway has been linked to neural crest development. The present study established a connection between the Pdgf pathway and Hif-1α stabilisation in zebrafish. Specifically, embryos with a disrupted Pdgf pathway were rescued by employing hif-1α mRNA through qPCR and immunohistochemistry techniques. The data suggest that oxygen levels in the neural crest are normal and that Pdgf1aa regulates neural crest migration through Hif-1α expression.


Asunto(s)
Movimiento Celular/genética , Subunidad alfa del Factor 1 Inducible por Hipoxia/genética , Cresta Neural/crecimiento & desarrollo , Oxígeno/metabolismo , Proteínas de Pez Cebra/genética , Pez Cebra/genética , Animales , Transición Epitelial-Mesenquimal/genética , Organogénesis/genética , Xenopus laevis/genética
2.
Oncogene ; 25(57): 7545-53, 2006 Dec 04.
Artículo en Inglés | MEDLINE | ID: mdl-17143299

RESUMEN

In order to function properly, the brain must be wired correctly during critical periods in early development. Mistakes in this process are hypothesized to occur in disorders like autism and schizophrenia. Later in life, signaling pathways are essential in maintaining proper communication between neuronal and non-neuronal cells, and disrupting this balance may result in disorders like Alzheimer's disease. The Wnt/beta-catenin pathway has a well-established role in cancer. Here, we review recent evidence showing the involvement of Wnt/beta-catenin signaling in neurodevelopment as well as in neurodegenerative diseases. We suggest that the onset/development of such pathological conditions may involve the additive effect of genetic variation within Wnt signaling components and of molecules that modulate the activity of this signaling cascade.


Asunto(s)
Regulación de la Expresión Génica , Enfermedades del Sistema Nervioso/metabolismo , Proteínas Wnt/fisiología , Enfermedad de Alzheimer/metabolismo , Animales , Apolipoproteínas E/metabolismo , Trastorno Autístico , Variación Genética , Humanos , Enfermedades Neurodegenerativas/metabolismo , Polimorfismo Genético , Esquizofrenia/genética , Esquizofrenia/metabolismo , Transducción de Señal , Proteínas Wnt/metabolismo
3.
Mol Psychiatry ; 8(2): 195-208, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12610652

RESUMEN

Alzheimer's disease (AD) is a progressive neurodegenerative disorder, which is probably caused by the cytotoxic effect of the amyloid beta-peptide (Abeta). We report here molecular changes induced by Abeta, both in neuronal cells in culture and in rats injected in the dorsal hippocampus with preformed Abeta fibrils, as an in vivo model of the disease. Results indicate that in both systems, Abeta neurotoxicity resulted in the destabilization of endogenous levels of beta-catenin, a key transducer of the Wnt signaling pathway. Lithium chloride, which mimics Wnt signaling by inhibiting glycogen synthase kinase-3beta promoted the survival of post-mitotic neurons against Abeta neurotoxicity and recovered cytosolic beta-catenin to control levels. Moreover, the neurotoxic effect of Abeta fibrils was also modulated with protein kinase C agonists/inhibitors and reversed with conditioned medium containing the Wnt-3a ligand. We also examined the spatial memory performance of rats injected with preformed Abeta fibrils in the Morris water maze paradigm, and found that chronic lithium treatment protected neurodegeneration by rescuing beta-catenin levels and improved the deficit in spatial learning induced by Abeta. Our results are consistent with the idea that Abeta-dependent neurotoxicity induces a loss of function of Wnt signaling components and indicate that lithium or compounds that mimic this signaling cascade may be putative candidates for therapeutic intervention in Alzheimer's patients.


Asunto(s)
Enfermedad de Alzheimer/metabolismo , Degeneración Nerviosa/metabolismo , Proteínas/metabolismo , Transducción de Señal/fisiología , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/patología , Péptidos beta-Amiloides/metabolismo , Animales , Conducta Animal/efectos de los fármacos , Muerte Celular/efectos de los fármacos , Muerte Celular/fisiología , Células Cultivadas , Medios de Cultivo Condicionados/farmacología , Proteínas del Citoesqueleto/metabolismo , Humanos , Isoenzimas/metabolismo , Riñón/citología , Litio/farmacología , Trastornos de la Memoria/metabolismo , Trastornos de la Memoria/patología , Ratones , Degeneración Nerviosa/tratamiento farmacológico , Degeneración Nerviosa/patología , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Neuronas/patología , Proteína Quinasa C/metabolismo , Proteínas/genética , Ratas , Ratas Sprague-Dawley , Transactivadores/metabolismo , Transfección , Proteínas Wnt , Proteína Wnt3 , Proteína Wnt3A , beta Catenina
4.
Biochemistry ; 40(35): 10447-57, 2001 Sep 04.
Artículo en Inglés | MEDLINE | ID: mdl-11523986

RESUMEN

Acetylcholinesterase (AChE) has been found to be associated with the core of senile plaques. We have shown that AChE interacts with the amyloid beta-peptide (Abeta) and promotes amyloid fibril formation by a hydrophobic environment close to the peripheral anionic binding site (PAS) of the enzyme. Here we present evidence for the structural motif of AChE involved in this interaction. First, we modeled the docking of Abeta onto the structure of Torpedo californica AChE, and identified four potential sites for AChE-Abeta complex formation. One of these, Site I, spans a major hydrophobic sequence exposed on the surface of AChE, which had been previously shown to interact with liposomes [Shin et al. (1996) Protein Sci. 5, 42-51]. Second, we examined several AChE-derived peptides and found that a synthetic 35-residue peptide corresponding to the above hydrophobic sequence was able to promote amyloid formation. We also studied the ability to promote amyloid formation of two synthetic 24-residue peptides derived from the sequence of a Omega-loop, which has been suggested as an AChE-Abeta interacting motif. Kinetic analyses indicate that only the 35-residue hydrophobic peptide mimics the effect of intact AChE on amyloid formation. Moreover, RP-HPLC analysis revealed that the 35-residue peptide was incorporated into the growing Abeta-fibrils. Finally, fluorescence binding studies showed that this peptide binds Abeta with a K(d) = 184 microM, independent of salt concentration, indicating that the interaction is primarily hydrophobic. Our results indicate that the homologous human AChE motif is capable of accelerating Abeta fibrillogenesis.


Asunto(s)
Acetilcolinesterasa/química , Péptidos beta-Amiloides/química , Placa Amiloide/química , Acetilcolinesterasa/aislamiento & purificación , Secuencia de Aminoácidos , Animales , Química Encefálica , Bovinos , Humanos , Modelos Moleculares , Datos de Secuencia Molecular , Placa Amiloide/ultraestructura , Conformación Proteica , Solubilidad , Torpedo
5.
Brain Res Brain Res Rev ; 33(1): 1-12, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10967351

RESUMEN

Alzheimer's disease (AD) is a neurodegenerative disease with progressive dementia accompanied by three main structural changes in the brain: diffuse loss of neurons; intracellular protein deposits termed neurofibrillary tangles (NFT) and extracellular protein deposits termed amyloid or senile plaques, surrounded by dystrophic neurites. Two major hypotheses have been proposed in order to explain the molecular hallmarks of the disease: The 'amyloid cascade' hypothesis and the 'neuronal cytoskeletal degeneration' hypothesis. While the former is supported by genetic studies of the early-onset familial forms of AD (FAD), the latter revolves around the observation in vivo that cytoskeletal changes - including the abnormal phosphorylation state of the microtubule associated protein tau - may precede the deposition of senile plaques. Recent studies have suggested that the trafficking process of membrane associated proteins is modulated by the FAD-linked presenilin (PS) proteins, and that amyloid beta-peptide deposition may be initiated intracellularly, through the secretory pathway. Current hypotheses concerning presenilin function are based upon its cellular localization and its putative interaction as macromolecular complexes with the cell-adhesion/signaling beta-catenin molecule and the glycogen synthase kinase 3beta (GSK-3beta) enzyme. Developmental studies have shown that PS proteins function as components in the Notch signal transduction cascade and that beta-catenin and GSK-3beta are transducers of the Wnt signaling pathway. Both pathways are thought to have an important role in brain development, and they have been connected through Dishevelled (Dvl) protein, a known transducer of the Wnt pathway. In addition to a review of the current state of research on the subject, we present a cell signaling model in which a sustained loss of function of Wnt signaling components would trigger a series of misrecognition events, determining the onset and development of AD.


Asunto(s)
Enfermedad de Alzheimer/metabolismo , Enfermedad de Alzheimer/fisiopatología , Proteínas Proto-Oncogénicas/metabolismo , Transducción de Señal/fisiología , Proteínas de Pez Cebra , Enfermedad de Alzheimer/patología , Animales , Humanos , Proteínas Wnt
6.
J Neurosci Res ; 52(4): 435-44, 1998 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-9589388

RESUMEN

Alzheimer's disease (AD) is associated with a reduction in cholinergic activity as a result of specific neuronal loss. Current potential treatments for the disease include both cholinomimetic drugs and anticholinesterase inhibitors. One of the drugs approved by the FDA is tacrine (9-amine-1,2,3,4 tetrahydroacridine; THA), a strong acetylcholinesterase (AChE) inhibitor. We have studied the effects of tacrine on glial and neuronal cells in culture assessing cell survival and viability and morphology. Lactate dehydrogenase (LDH) activity and methylthiazol-diphenyl-tetrazolium (MTT) reduction were used as toxicity indicators. We found that tacrine toxicity on rat B12 glial cells and mouse Neuro 2A cells was strongly dependent on its concentration (up to 500 microM) and time of exposure. The toxic effect was not prevented by serum factors nor by bovine serum albumin. Fluorescein-conjugated phalloidin was used to examine the arrangement of actin filaments at substrate adhesion regions and cell-cell contacts. Primary events following exposure to tacrine included changes in cell morphology, disappearance of actin filament bundles, and disruption of focal adhesion contacts. At concentrations between 10 and 50 microM, tacrine induced neurite outgrowth in Neuro 2A cells, an effect that was not observed in B12 cells, suggesting that certain tacrine effects could be specific for neuronal cells. Although similar trends of response were observed for both cell types, some differences between undifferentiated and differentiated cells were apparent.


Asunto(s)
Neuronas/efectos de los fármacos , Tacrina/toxicidad , Animales , Diferenciación Celular/efectos de los fármacos , Tamaño de la Célula/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Glioma , Ratones , Neuroblastoma , Neuroglía/efectos de los fármacos , Neuronas/patología , Ratas , Células Tumorales Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA